- 注册
- 2005-11-23
- 消息
- 30,291
- 荣誉分数
- 7,455
- 声望点数
- 373
1 hr 11 min ago
Vaccine advisers to the US Centers for Disease Control and Prevention are meeting now to discuss Covid-19 booster shots. Their meeting comes a day after the US Food and Drug Administration granted emergency use authorization for a booster dose of Pfizer's vaccine for some people.
Currently, members are discussing the questions to vote on. They are considering the following policy questions:
These are the questions CDC advisers are discussing
From CNN's Maggie FoxVaccine advisers to the US Centers for Disease Control and Prevention are meeting now to discuss Covid-19 booster shots. Their meeting comes a day after the US Food and Drug Administration granted emergency use authorization for a booster dose of Pfizer's vaccine for some people.
Currently, members are discussing the questions to vote on. They are considering the following policy questions:
- Should adults 65 years of age and older and long-term care facility residents receive a Pfizer-BioNTech Covid-19 vaccine booster dose?
- Should adults 18-64 years of age at risk for severe Covid-19 due to underlying medical conditions receive a Covid-19 vaccine booster dose?
- Should adults 18-64 years of age at risk of SARS-CoV-2 exposure due to occupation or setting receive a Pfizer-BioNTech Covid-19 vaccine booster dose?